BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25625987)

  • 1. Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates.
    Skoglund K; Hjortdal O
    Tidsskr Nor Laegeforen; 2015 Jan; 135(2):116-7. PubMed ID: 25625987
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A; Blanco R
    Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Re: Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates].
    Eriksen EF
    Tidsskr Nor Laegeforen; 2015 Jun; 135(10):921. PubMed ID: 26037748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Re: Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates].
    Strømsøe K
    Tidsskr Nor Laegeforen; 2015 Feb; 135(4):309. PubMed ID: 25707643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with bisphosphonates as a possible cause of bilateral spontaneous atypical femoral fracture].
    Rasmussen M; Lange J
    Ugeskr Laeger; 2012 Jan; 174(1-2):32-3. PubMed ID: 22233718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subtrochanteric pathological fracture on bisphosphonates].
    Mathonet PY; Willems S; Ciornohac JF
    Rev Med Liege; 2018 Feb; 73(2):56-60. PubMed ID: 29517866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonates treatment in patients with osteoporosis].
    Rizzoli R
    Ther Umsch; 2012 Mar; 69(3):173-81. PubMed ID: 22403110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Murray JC; Audet MC; Bédard M; Michou L
    Osteoporos Int; 2016 Feb; 27(2):833-6. PubMed ID: 26556740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology: Discontinuation of bisphosphonates.
    Malden N; Loh S
    Br Dent J; 2017 Jan; 222(2):67-8. PubMed ID: 28127004
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures: diagnostic features on bone scan.
    Probst S; Rakheja R; Stern J
    Clin Nucl Med; 2013 May; 38(5):397-9. PubMed ID: 23478849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report.
    Pan WL; Chen PL; Lin CY; Pan YC; Ju YR; Chan CP; Hsu RW
    Clin Interv Aging; 2017; 12():1089-1093. PubMed ID: 28744112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy.
    Shaikh W; Morris D; Morris S
    J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biphosphonate-induced femoral stress fractures : A new problem and knowledge so far - case report].
    Lenz R; Ellenrieder M; Skripitz R; Bader R; Pautke C; Mittelmeier W; Tischer T
    Orthopade; 2011 Dec; 40(12):1111-8. PubMed ID: 21678088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
    Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do not use bisphosphonate therapy indefinitely for fracture prevention.
    Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
    Gopal GK; Tam KL; Krishnan SP; Maddern IL
    N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate fractures as a cause of painful total hip arthroplasty.
    Curtin BM; Fehring TK
    Orthopedics; 2011 Dec; 34(12):e939-44. PubMed ID: 22146214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.